» Articles » PMID: 15108256

Bone Mineral Density Among Cirrhotic Patients Awaiting Liver Transplantation

Overview
Journal Liver Transpl
Date 2004 Apr 27
PMID 15108256
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Osteoporosis is an important and common complication in patients with chronic liver disease. The goal of this study was to determine the bone mineral density (BMD) in different subgroups among pretransplant cirrhotic patients. BMD of the lumbar vertebrae (L) and femoral neck (F) were obtained in 104 consecutive cirrhotic patients. Descriptive and inferential statistics were used to compare the BMD among various groups. The mean BMD in males (n = 54) and females (n = 50) at L were 1.28 +/- 0.25 g/cm(2) and 1.13 +/- 0.20 g/cm(2), respectively (P =.001); at F they were 1.03 +/- 0.14 and 0.91 +/- 0.17, respectively (P <.0001). Among males, BMD at L in Child-Turcotte-Pugh class B and C were 1.40 +/- 0.21 and 1.13 +/- 0.20, respectively (P =.001); at F they were 1.11 +/- 0.10 and 0.93 +/- 0.13, respectively (P <.0001). Among females, BMD at L in Child-Turcotte-Pugh class B and C were 1.27 +/- 0.18 and 1.05 +/- 0.16, respectively (P =.0003); at F they were 1.02 +/- 0.16 and 0.83 +/- 0.12, respectively (P =.001). The BMD in premenopausal females (n = 15) and postmenopausal females (n = 35) at L were 1.20 +/- 0.19 and 1.11 +/- 0.20, respectively (P =.15); at F they were 0.97 +/- 0.17 and 0.88 +/- 0.16, respectively (P =.12). The BMD in postmenopausal females on hormone replacement therapy (n = 19) and on no hormone replacement therapy (n = 16) at L were 1.07 +/- 0.17 and 1.14 +/- 0.23, respectively (P =.29); at F they were 0.85 +/- 0.15 and 0.91 +/- 0.18, respectively (P =.33). The BMD values between etiologic groups were not significantly different. The overall prevalence of osteopenia and osteoporosis were 34.6% and 11.5%, respectively, being significantly higher in females than in males. In conclusion, significant difference in BMD values exists between males and females, as well as between Child-Turcotte-Pugh class B and C patients with cirrhosis. In addition, there is no significant influence of menopausal status, hormone replacement therapy, and etiology of cirrhosis on BMD.

Citing Articles

Osteoporosis and Fragility Fractures in Patients with Liver Cirrhosis: Usefulness of FRAX as a Screening Tool.

Sanchez-Delgado J, Profitos J, Arevalo M, Lira A, Marmol C, Miquel M J Clin Med. 2024; 13(1).

PMID: 38202195 PMC: 10780144. DOI: 10.3390/jcm13010188.


Vitamin D status & bone health in patients with liver cirrhosis.

Grover I, Singh N, Gunjan D, Benjamin J, Ramakrishnan L, Pandey R Indian J Med Res. 2023; 158(3):284-291.

PMID: 37815065 PMC: 10720958. DOI: 10.4103/ijmr.IJMR_1144_20.


Prevalence of Osteoporosis in Cirrhosis: A Systematic Review and Meta-Analysis.

Kang J, Gopakumar H, Puli S Cureus. 2023; 15(1):e33721.

PMID: 36788896 PMC: 9922208. DOI: 10.7759/cureus.33721.


Incidence of malnutrition and changes in phosphocalcic metabolism in perioperative liver transplantation patients -a retrospective study in a tertiary children's hospital in China.

Pan L, Gao X, Fu H, Liu Y, Hong L BMC Pediatr. 2022; 22(1):719.

PMID: 36522616 PMC: 9753393. DOI: 10.1186/s12887-022-03790-5.


An Overview of the Molecular Mechanisms Contributing to Musculoskeletal Disorders in Chronic Liver Disease: Osteoporosis, Sarcopenia, and Osteoporotic Sarcopenia.

Yang Y, Kim D Int J Mol Sci. 2021; 22(5).

PMID: 33807573 PMC: 7961345. DOI: 10.3390/ijms22052604.